Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding IVBUF?
Track your performance easily
IVBUF Price & Analysis
IVBUF ETF Chart & Stats
Day’s Range― - ―
52-Week Range$5.38 - $6.75
Previous Close$6.75
VolumeN/A
Average Volume (3M)3.69K
AUM535.15M
NAV6.97
Expense Ratio0.35%
Holdings Count216
Beta0.28
Inception DateOct 19, 2017
Next Dividend Ex-DateN/A
Dividend YieldN/A
Shares Outstanding74,607,734
Standard Deviation0.07
10 Day Avg. Volume1,598
30 Day Avg. Volume3,691
Alpha0.00112
iShares NASDAQ US Biotechnology UCITS ETF (IVBUF) Fund Flow Chart
iShares NASDAQ US Biotechnology UCITS ETF (IVBUF) 1 year Net Flows: $531K
IVBUF ETF News
IVBUF ETF FAQ
What was IVBUF’s price range in the past 12 months?
IVBUF lowest ETF price was $5.38 and its highest was $6.75 in the past 12 months.
What is the AUM of IVBUF?
As of Jul 12, 2024 The AUM of IVBUF is 535.15M.
Is IVBUF overvalued?
According to Wall Street analysts IVBUF’s price is currently Undervalued.
Does IVBUF pay dividends?
IVBUF does not currently pay dividends.
How many shares outstanding does IVBUF have?
IVBUF has 74,607,734 shares outstanding.
Which hedge fund is a major shareholder of IVBUF?
Currently, no hedge funds are holding shares in IVBUF
IVBUF ETF Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Regeneron Pharmaceuticals
8.11%
Gilead Sciences
8.01%
Vertex Pharmaceuticals Inc.
7.95%
Amgen Inc
7.82%
Moderna
4.59%
AstraZeneca
3.68%
Biogen Inc.
3.41%
Alnylam Pharmaceuticals
3.27%
Illumina
1.86%
Biomarin Pharmaceutical Inc.
1.58%
Total50.28%
ETF Description
iShares NASDAQ US Biotechnology UCITS ETF
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.